期刊文献+

c-erbB-2、p53、p21基因表达与胃癌及大肠癌预后因素的关系 被引量:1

Relationship between cerbB,p53,p21 Expression and Prognostic Factors in Gastric and Colorectal Cancers
暂未订购
导出
摘要 应用ABC免疫组织化学染色方法检测120例胃癌和大肠癌的癌肿内及转移淋巴结中c-erbB-2、p53、p21基因的过度表达。多基因阳性在胃癌中占66.7%;大肠癌中占68.3%,多基因表达明显提示胃癌及大肠癌预后差。单基因阳性亦分别显示胃癌及大肠癌预后较差。转移淋巴结与胃癌及大肠癌的原发癌肿之间基因过度表达与否的平均符合率c-erbB-2为83.1%;p53为75.3%;p21为77.9%,表明转移淋巴结中的基因过度表达与否与原发癌肿相似。c-erbB-2、p53、p21的多基因表达的检测对胃癌和大肠癌的预后判断明显优于其中某个单基因表达的检测。 The overexpression of cerbB2,p53 and p21 in 120 cases of gastric and colorectal cancers and their metastatic lymph nodes were studied immunohistochemically.The multiple gene positive rate in gastric cancer was 66.7% and that in colorectal cancer was 68.3%.The polygene overexpression significantly indicated poor prognosis of gastric and colorectal cancers,just as anyone single gene overexpression.The mean coincident rates of overexpression or nonoverexpression of cerbB2,p53,p21 in metastatic lymph nodes and the primary gastric and colorectal cancers were 83.1%,75.3% and 77.9% respectively which means that overexpression in metastatic lymph nodes paralleled that in the primary tumors.Determination of overexpression of cerbB2,p53 and p21 simultaneously was superior that of any one gene singly in evaluating the prognosis of gastric and colorectal cancers.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 1998年第4期296-298,共3页 Chinese Journal of Clinical Oncology
关键词 胃癌 大肠癌 肿瘤基因 基因表达 预后 Gastric cancer Colorectal cancer Oncogene PrognosisGene expression
  • 相关文献

参考文献2

  • 1王俊茹,中华消化杂志,1995年,15卷,133页
  • 2杨定成,中华肿瘤杂志,1995年,17卷,175页

同被引文献8

  • 1Joncourt F,Buser K,Altermatt H,et al. Multiple drug resistance parameter expression in ovarian cancer[J]. Gymecol Oncol,1998,70(2):176-182.
  • 2Pujol JL,Simony J,Gautier V,et al. Immunlhistochemical study of P-glycoprotein distribution in lung cancer[J].Lung Cancer,1993,10(1-2):1.
  • 3Goto S,lida T,Cho S,et al. Overexpression of glutathione Stransferaseπ enhances the adduct formation of cisplatin with glutathione in human cancer cells[J]. Free Radi Res,1999,31(6):549-558.
  • 4Donald G,Guinee JR,Joseph A,et al. Comparison of DNA topoisomerase Ⅱ a expression in small cell and non small cell carcinoma of the lung[J]. Cancer,1996,78:729-735.
  • 5Toffoli G,Viel A,Tumiotto L, et al.Expression of glutathione-s-transferase π in human tumors[J].Eur J Cancer,1992,28:1441.
  • 6沈历宗.大肠癌多药耐药性研究进展[J].国外医学(外科学分册),1998,25(4):218-222. 被引量:13
  • 7柳红,吴永平.大肠癌p53、p21和c-erbB-2蛋白协同表达的病理学及预后意义[J].癌症,1998,17(5):382-383. 被引量:2
  • 8陈小岩,施作霖,李燕辉.结直肠癌组织中P-gp、GST-π、Topo-Ⅱ和p53的协同表达[J].临床与实验病理学杂志,2002,18(6):608-610. 被引量:11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部